" class="no-js "lang="en-US"> Matthias Hebben - Medtech Alert
Friday, August 15, 2025
Matthias Hebben

Matthias Hebben

About Matthias Hebben

Matthias Hebben brings nearly 20 years of scientific, technical and leadership experience in virology, specifically in the development, manufacturing and characterization of viral vectors for delivery of gene therapy. Before joining LogicBio, he served as director, AAV technology and CMC development at Genenthon. Before that, he served as director, R&D virology at Valneva (formerly Vivalis). Matthias received his Ph.D. in molecular and cellular biology from The Nice Sophia Antipolis University and his B.Eng. in biotechnology from Louis Pasteur University.

Related Story

Exothera Announces Industrial Scale AAV Manufacturing Collaboration With LogicBio Therapeutics and Polyplus

June 15 2022

Exothera SA today announced a collaboration with LogicBio® Therapeutics and Polyplus-transfection® SA. for the development of […]